Literature DB >> 12392558

Extra terminal residues have a profound effect on the folding and solubility of a Plasmodium falciparum sexual stage-specific protein over-expressed in Escherichia coli.

Sushil Prasad Sati1, Saurabh Kumar Singh, Nirbhay Kumar, Amit Sharma.   

Abstract

The presence of extra N- and C- terminal residues can play a major role in the stability, solubility and yield of recombinant proteins. Pfg27 is a 27K soluble protein that is essential for sexual development in Plasmodium falciparum. It was over-expressed using the pMAL-p2 vector as a fusion protein with the maltose binding protein. Six different constructs were made and each of the fusion proteins were expressed and purified. Our results show that the fusion proteins were labile and only partially soluble in five of the constructs resulting in very poor yields. Intriguingly, in the sixth construct, the yield of soluble fusion protein with an extended carboxyl terminus of 17 residues was several fold higher. Various constructs with either N-terminal or smaller C-terminal extensions failed to produce any soluble fusion protein. Furthermore, all five constructs produced Pfg27 that precipitated after protease cleavage from its fusion partner. The sixth construct, which produced soluble protein in high yields, also gave highly stable and soluble Pfg27 after cleavage of the fusion. These results indicate that extra amino acid residues at the termini of over-expressed proteins can have a significant effect on the folding of proteins expressed in E. coli. Our data suggest the potential for development of a novel methodology, which will entail construction of fusion proteins with maltose binding protein as a chaperone on the N-terminus and a C-terminal 'solubilization tag'. This system may allow large-scale production of those proteins that have a tendency to misfold during expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12392558     DOI: 10.1046/j.1432-1033.2002.03237.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli.

Authors:  Susan Idicula-Thomas; Petety V Balaji
Journal:  Protein Sci       Date:  2005-02-02       Impact factor: 6.725

2.  IL-33trap is a novel IL-33-neutralizing biologic that inhibits allergic airway inflammation.

Authors:  Aurora Holgado; Harald Braun; Elien Van Nuffel; Sammy Detry; Martijn J Schuijs; Kim Deswarte; Karl Vergote; Mira Haegman; Griet Baudelet; Jurgen Haustraete; Hamida Hammad; Bart N Lambrecht; Savvas N Savvides; Inna S Afonina; Rudi Beyaert
Journal:  J Allergy Clin Immunol       Date:  2019-03-13       Impact factor: 10.793

3.  India Needs to Consider Planning a Change to Artemether-Lumefantrine to Treat Plasmodium falciparum Malaria.

Authors:  Manju Rahi; Rini Chaturvedi; Ritu Goswami; Amit Sharma
Journal:  Am J Trop Med Hyg       Date:  2022-03-14       Impact factor: 3.707

4.  Prediction of solubility on recombinant expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli.

Authors:  Sanjay Ahuja; Satpal Ahuja; Qijun Chen; Mats Wahlgren
Journal:  Malar J       Date:  2006-06-25       Impact factor: 2.979

5.  Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli.

Authors:  Hans Peter Sørensen; Kim Kusk Mortensen
Journal:  Microb Cell Fact       Date:  2005-01-04       Impact factor: 5.328

6.  An encoded N-terminal extension results in low levels of heterologous protein production in Escherichia coli.

Authors:  Samantha S Orchard; Heidi Goodrich-Blair
Journal:  Microb Cell Fact       Date:  2005-07-21       Impact factor: 5.328

7.  Aminoacyl tRNA synthetases as potential drug targets of the Panthera pathogen Babesia.

Authors:  Jyoti Chhibber-Goel; Sarthak Joshi; Amit Sharma
Journal:  Parasit Vectors       Date:  2019-10-14       Impact factor: 3.876

Review 8.  Strategies to optimize protein expression in E. coli.

Authors:  Dana M Francis; Rebecca Page
Journal:  Curr Protoc Protein Sci       Date:  2010-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.